Tech Company Financing Transactions

Tolera Therapeutics Funding Round

Private investors participated in a $1.5 million funding round for Tolera Therapeutics. The funding round was announced on 5/15/2012.

Transaction Overview

Announced On
5/15/2012
Transaction Type
Debt
Amount
$1,465,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
P.O. Box 970
Portage, MI 49081
USA
Email Address
Overview
Building upon research done at the University of Kentucky and the Cleveland Clinic, Tolera Therapeutics is developing and commercializing therapies for the immune suppression / modulation market with the goal of addressing unmet medical needs with safer, more targeted solutions to reduce the risk of serious and toxic side effects.
Profile
Tolera Therapeutics LinkedIn Company Profile
Social Media
Tolera Therapeutics Company Twitter Account
Company News
Tolera Therapeutics News
Facebook
Tolera Therapeutics on Facebook
YouTube
Tolera Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chairman
Suzette Dutch
  Suzette Dutch LinkedIn Profile  Suzette Dutch Twitter Account  Suzette Dutch News  Suzette Dutch on Facebook
Chief Executive Officer
Ashleigh Palmer
  Ashleigh Palmer LinkedIn Profile  Ashleigh Palmer Twitter Account  Ashleigh Palmer News  Ashleigh Palmer on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/15/2012: Ingenious Med venture capital transaction
Next: 5/15/2012: Sonitus Medical venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary